On September 27, 2021, the Office of the U.S. Trade Representative (USTR) announced that it was again continuing exclusions from Section 301 duties for certain medical care imports from China needed to address the COVID-19 pandemic. These exclusions were set to expire on September 30, 2021 (see Update of March 8, 2021), but have now been extended until November 14, 2021. This extension will allow USTR sufficient time to review the comments it received in response to its August 27, 2021 notice requesting public comments on whether any of the 99 product exclusions should be further extended for up to six months (see  Update of August 27, 2021).